Navadurga Surgicals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.53 M
as on 24-06-2024
- Revenue 6.70%
(FY 2020)
- Profit 0.52%
(FY 2020)
- Ebitda -7.58%
(FY 2020)
- Net Worth 19.37%
(FY 2020)
- Total Assets 19.46%
(FY 2020)
About Navadurga Surgicals India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.53 M.
Prabhu Shraddha and Smita Hemant serve as directors at the Company.
- CIN/LLPIN
U24303KA2012PTC063492
- Company No.
063492
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Navadurga Surgicals India Private Limited offer?
Navadurga Surgicals India Private Limited offers a wide range of products and services, including Urological & Obstetrics Instruments, Gynaecological Equipment, Surgical Instruments & Accessories, Retractors, Wheel Chairs, Crutches and Walker, Wheelchairs, Orthopedic Implants, Surgical Implants, Orthopedic Instruments, Maxillofacial Implants.
Who are the key members and board of directors at Navadurga Surgicals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhu Shraddha  | Director | 12-Mar-2020 | Current |
| Smita Hemant | Director | 11-Apr-2012 | Current |
Financial Performance of Navadurga Surgicals India.
Navadurga Surgicals India Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.7% increase. The company also saw a slight improvement in profitability, with a 0.52% increase in profit. The company's net worth Soared by an impressive increase of 19.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navadurga Surgicals India?
In 2018, Navadurga Surgicals India had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Apr 2023 | ₹0.53 M | Open |
How Many Employees Work at Navadurga Surgicals India?
Unlock and access historical data on people associated with Navadurga Surgicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navadurga Surgicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navadurga Surgicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
